細胞培養蛋白表面塗層市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

細胞培養蛋白表面塗層市場預計在預測期內的複合年增長率為 9.5%。

當 COVID-19 首次出現時，許多生物技術和製藥公司、各國政府和研究機構都致力於開發高效疫苗和新療法來治療該問題。 細胞培養促進了用於治療 COVID-19 的新疫苗的研製。

主要亮點

• 2022 年 7 月發表在《臨床病毒學雜誌》上的一篇報告發現，在培養物中分離出 SARS-CoV-2 的概率、出現症狀的天數較少和較低的 RT-PCR 循環閾值之間存在顯著的正相關。 因此，在 COVID-19 期間，細胞培養被用於正確診斷，這有望促進細胞培養蛋白表面塗層市場的增長。 對該病毒的研究仍在進行中，因此預計它將在未來產生重大影響。
• 幹細胞研究活動的增加、對蛋白質治療和靶向治療的需求增加以及對 3D 細胞培養的偏好超過 2D 細胞培養等主要因素正在推動預測期內的市場增長。它是。
• 優化細胞培養環境可讓細胞以真實且具有代表性的方式生長、發揮功能和存活。 細胞培養表面的蛋白質塗層用細胞外基質或蛋白質成分包裹細胞培養表面，以增強細胞在體外的生長和粘附。 預計幹細胞研究活動的增加將對市場增長產生積極影響。
• 例如，2022 年 6 月，哈佛幹細胞研究所 (HSCI) 開始為其 2022 年周期徵集種子資金。 該計劃的目的是資助幹細胞和再生生物學領域的創造性工作，以加速新的基於乾細胞的治療和療法的開發。 根據上述消息來源，贈款金額為每個項目每年 100,000 美元，最多兩年。 因此，研究資金可能會在預測期內促進乾細胞研究活動並推動市場增長。
• 但是，細胞培養蛋白表麵包被產品的高成本以及動物源性蛋白包被材料的使用限制可能會阻礙市場增長。

細胞培養蛋白表面塗層的市場趨勢

預測期內預塗微孔板有望增長

• 微孔板也稱為微孔板或微量滴定板或多孔板。 微孔板已成為分析研究和臨床診斷實驗室的標準工具。 根據細胞類型、傳代、來源和細胞培養基的組成，培養中的細胞以不同的方式粘附在培養板上，即使是在專門為細胞培養製造的塑料上生長也是如此。
• 在研究期間，在微孔板中，新的進展、批准和發布正在推動市場增長。 例如，2022 年 4 月，Porvair Sciences Sero Krystal PDL 系列塗層微孔板將為可重現的細胞培養設立新標準，即使是困難的細胞類型。
• 市場上先進的□標儀正在增加微孔板在生物技術中的使用，從而推動市場發展。 例如，2022 年 4 月，Molecular Devices LLC 宣布推出 SpectraMax mini 多模式□標儀，這是一種緊湊且經濟的解決方案，旨在節省研究人員的工作台空間和預算。 同樣，2022 年 2 月，BMG LABTECH 將推出 VANTAstar □標儀，進一步擴大其高品質德國製造儀器的範圍。 VANTAstar 是一款緊湊型多模式□標儀，具有三個功能，可輕鬆進行檢測設置並提高數據質量。
• 因此，此類進步和發布預計將通過該細分市場對市場產生重大影響。

據估計北美佔據最大的市場份額

• 北美以資助細胞培養實驗室和醫療保健研究而聞名。 預計在預測期內它將主導市場。 在美國，國立衛生研究院 (NIH) 每年都為乾細胞研究提供大量資金。 為了研究癌症疾病和個性化醫療，美國國家癌症研究所 (NCI) 向與大學和研究機構合作的公司分配了大量資金。
• 美國癌症協會預測，2022 年美國將新增 1,918,030 例癌症病例。 預計癌症患者的增加將在預測期內對市場產生重大影響，因為它增加了對涉及細胞培養的靶向治療的需求。 此外，2022 年 2 月，KromaTiD 推出了一套全面的細胞和血培養擴展、分離、處理和質量控制服務。 這些因素推動了細胞培養活動的重要性。
• 此外，市場主要參與者的擴張也會對市場產生重大影響。 例如，2021 年 7 月，全球生命科學試劑和工具的創新者 Abcam 在美國馬薩諸塞州沃爾瑟姆開設了一家大型新工廠。 新設施是 Abcam 在美國發展的核心組成部分，並加強了其支持研究和生物製藥行業的承諾。
• 因此，由於上述因素，預計北美地區的研究市場在預測期內將出現大幅增長。

細胞培養蛋白表面塗層市場競爭分析

細胞培養蛋白表面塗層市場較為分散，由幾家主要參與者組成。 主要市場參與者正專注於蛋白質技術和細胞培養技術的技術進步。 市場上的主要參與者包括 Abcam PLC、Corning Incorporated、Greiner AG（Greiner Bio-One International GmbH）、Merck KGaA、Promega Corporation、Sartorius AG、Qiagen NV、Viogene、Thermo Fisher Scientific Inc。

其他好處

• Excel 格式的市場預測 (ME) 表
• 三個月的分析師支持

內容

第一章介紹

• 研究假設和市場定義
• 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

• 市場概覽
• 市場驅動力
  • 啟動干細胞研究
  • 對蛋白質療法和靶向療法的需求不斷增長
  • 越來越喜歡從 2D 細胞培養到 3D 細胞培養
• 市場製約因素
  • 用於細胞培養的蛋白質表麵包被產品成本高
  • 限制使用動物來源的蛋白質塗層材料
• 波特的五力分析
  • 新進入者的威脅
  • 買方/消費者議價能力
  • 供應商的議價能力
  • 替代品的威脅
  • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

• 按蛋白質來源
  • 動物來源的蛋白質
  • 人源蛋白
  • 合成蛋白質
  • 植物來源的蛋白質
• 按塗層類型
  • 自塗層
  • 預塗
    • 微孔板
    • 培養皿
    • 燒瓶
    • 幻燈片
    • 其他預塗劑
• 按地區
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 中東和非洲
    • 海灣合作委員會
    • 南非
    • 其他中東地區
  • 南美洲地區
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章競爭格局

• 公司簡介
  • Abcam PLC
  • Corning Incorporated
  • Greiner AG（Greiner Bio-One International GmbH）
  • Merck KGaA
  • Promega Corporation
  • Qiagen NV
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Viogene

第7章 市場機會與今後動向

The cell culture protein surface coatings market is expected to register a CAGR of 9.5% over the forecast period. When COVID-19 first appeared, a lot of biotech and pharmaceutical companies, governments from different nations, and research institutions began to concentrate on the creation of efficient vaccines and novel treatments to treat the problem. The creation of new vaccines for the treatment of COVID-19 was facilitated by cell culture.

Key Highlights

• As per the report published by the Journal of Clinical Virology in July 2022, there was a significant positive correlation between the probability of isolating SARS-CoV-2 in culture, fewer days of symptoms, and a lower RT-PCR cycle threshold value. Hence the cell culture was used during COVID-19 for proper diagnosis and was expected to grow the cell culture protein surface coatings market. As viral studies are still ongoing, it is expected to have a significant impact in the coming future.
• The major factors, such as increasing stem cell research activities, increasing demand for protein therapeutics and targeted therapy, and growing preference for 3D cell cultures over 2D cell cultures, are driving the growth of the market over the forecast period.
• The optimization of the cell culture environment enables cells to grow, function, and survive in a realistic and representative manner. The surface coating of cell culture with protein involves coating the cell culture surface with extracellular matrix or protein components to improve the proliferation and adhesion of the cells in-vitro. Increasing stem cell research activities are expected to have a positive impact on the growth of the market.
• For instance, in June 2022, the Harvard Stem Cell Institute (HSCI) invited applications for seed grant funding for its 2022 cycle. The program's objective is to offer financial support for creative initiatives in the field of stem cell and regenerative biology to accelerate the development of new stem cell-based therapies or cures. As per the same above-mentioned source, the amounted award is USD 100,000 per project per year for up to two years. Thus the funding for the research activities increases the stem cell research activities that may drive the growth of the market over the forecast period.
• However, the high cost of cell culture protein surface coatings products and restrictions against the use of animal-source protein coating material may impede the growth of the market.

Cell Culture Protein Surface Coatings Market Trends

Microwell Plates Under Pre-coatings Expected to Grow Over the Forecast Period

• Microwell plates are also known as microplates or microtiter plates, or multiwells. The microplate has become a standard tool in analytical research and clinical diagnostic testing laboratories. Depending on the cell type, passage, origin, and makeup of the cell culture media, cells in culture adhere to the culture plates in various ways, even when they are grown on plastic made specifically for cell culture.
• The new advancements and approvals, and launches among the microwell plates drive the market growth over the study period. For instance, in April 2022, the Porvair Sciences Sero Krystal PDL family of coated microplates sets a new standard for repeatable cell culture, even with difficult cell types.
• The advanced microplate readers in the market increase the usage of microplates in biotechnology that, drive the market. For instance, in April 2022, Molecular Devices LLC launched its SpectraMax mini multi-mode microplate reader, a compact and economical solution designed to save researchers benchtop space and budget. Similarly, in February 2022, BMG LABTECH launched the VANTAstar microplate reader, further expanding its range of high-quality, made-in-Germany instruments. VANTAstar is a compact multi-mode microplate reader and is equipped with three features that enable an effortless detection setup and improve data quality.
• Hence, the above advancements and launches are expected to have a significant impact on the market through the segment.

North America Estimated to Hold the Largest Share in the Market

• North America is well known for its cell culture laboratories and funding for research in the healthcare domain. And it is expected to dominate the market over the forecast period. Every year in United States, the National Institutes of Health (NIH) heavily funds stem cell research. For research in cancer diseases and personalized medicine, the National Cancer Institute (NCI) allocates high funds to universities and companies collaborating with research centers.
• The American Cancer Society predicts that in 2022, there will be an estimated 1,918,030 new cases of cancer in United States. The rise in cancer cases increases the demand for targeted therapies which involve cell cultures and hence are expected to have a significant impact on the market over the forecast period. Additionally, in February 2022, KromaTiD launched a comprehensive suite of cell and blood culture growth, isolation, processing, and quality control services. Such factors boost the importance of cell culture activities.
• Additionally, the expansion of the major players in the market also has a significant impact on the market. For instance, in July 2021, Abcam, a global innovator in life sciences reagents and tools, opened a major new site in Waltham, Massachusetts, United States. The new facility is a central component of Abcam's growth in United States, reinforcing its commitment to support the research and biopharma sector.
• Thus, owing to the abovementioned factors, the studied market in the North American region is expected to show considerable growth over the forecast period.

Cell Culture Protein Surface Coatings Market Competitive Analysis

The cell culture protein surface coating market is moderately fragmented and consists of several major players. The major market players are focusing on technological advancements in protein technology and cell culture techniques. Some of the major players in the market are Abcam PLC, Corning Incorporated, Greiner AG (Greiner Bio-One International GmbH), Merck KGaA, Promega Corporation, Sartorius AG, Qiagen NV, Viogene, and Thermo Fisher Scientific Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Stem Cell Research Activities
  • 4.2.2 Increasing Demand of Protein Therapeutics and Targeted Therapy
  • 4.2.3 Growing Preference for 3D Cell Cultures over 2D Cell Cultures
• 4.3 Market Restraints
  • 4.3.1 High Cost of Cell Culture Protein Surface Coatings Products
  • 4.3.2 Restriction Against Use of Animal Source Protein Coating Material
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

• 5.1 By Protein Source
  • 5.1.1 Animal-derived Protein
  • 5.1.2 Human-derived Protein
  • 5.1.3 Synthetic Protein
  • 5.1.4 Plant-derived Protein
• 5.2 By Type of Coating
  • 5.2.1 Self-coating
  • 5.2.2 Pre-coating
    • 5.2.2.1 Microwell Plates
    • 5.2.2.2 Petri Dish
    • 5.2.2.3 Flask
    • 5.2.2.4 Slides
    • 5.2.2.5 Other Types of Pre-coatings
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 France
    • 5.3.2.2 Germany
    • 5.3.2.3 United Kingsom
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Abcam PLC
  • 6.1.2 Corning Incorporated
  • 6.1.3 Greiner AG (Greiner Bio-One International GmbH)
  • 6.1.4 Merck KGaA
  • 6.1.5 Promega Corporation
  • 6.1.6 Qiagen NV
  • 6.1.7 Sartorius AG
  • 6.1.8 Thermo Fisher Scientific Inc.
  • 6.1.9 Viogene

7 MARKET OPPORTUNITIES AND FUTURE TRENDS